Ariel Focus Fund buys AJG, PBH and FI; exits ZIMV, CLB and BIO

* Ariel Focus Fund outperformed the Russell 1000 Value Index and S&P 500 Index by registering a growth of 20.76% in Q3 2025. While the Russell 1000 Value Index posted a gain of 5.33%, the S&P 500 Index registered a return of 8.12%.
* In Q3 2025, the fund initiated new positions in Prestige Consumer Healthcare (NYSE:PBH [https://seekingalpha.com/symbol/PBH]), Arthur J. Gallagher (NYSE:AJG [https://seekingalpha.com/symbol/AJG]), and Fiserv (NYSE:FI [https://seekingalpha.com/symbol/FI]).
* During the third quarter, the fund exited Zimvie (ZIMV [https://seekingalpha.com/symbol/ZIMV-DEFUNCT-615269]), Core Laboratories (NYSE:CLB [https://seekingalpha.com/symbol/CLB#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link]), and Bio-Rad Laboratories (NYSE:BIO). [https://seekingalpha.com/symbol/BIO]
* Source [https://seekingalpha.com/article/4832896-ariel-focus-fund-q3-2025-commentary].

MORE ON PRESTIGE CONSUMER HEALTHCARE, ARTHUR J.GALLAGHER, ETC.

* Core Laboratories Inc. (CLB) Q3 2025 Earnings Call Transcript [https://seekingalpha.com/article/4832445-core-laboratories-inc-clb-q3-2025-earnings-call-transcript]
* Fiserv: Q3 Preview, Strong Fundamentals And Weak Sentiment [https://seekingalpha.com/article/4832191-fiserv-q3-preview-strong-fundamentals-weak-sentiment]
* Arthur J. Gallagher & Co.: Fairly Valued Global Insurance Broker [https://seekingalpha.com/article/4828811-arthur-j-gallagher-and-co-fairly-valued-global-insurance-broker]
* Core Laboratories projects Q4 2025 revenue of $132M–$136M as international demand drives growth [https://seekingalpha.com/news/4507639-core-laboratories-projects-q4-2025-revenue-of-132m-136m-as-international-demand-drives-growth]
* Core Laboratories Q3 2025 Earnings Preview [https://seekingalpha.com/news/4506264-core-laboratories-q3-2025-earnings-preview]